N
Nong Woo Bio Co Ltd
KOSDAQ:054050
Nong Woo Bio Co Ltd
KOSDAQ:054050
Price:
8 350
KRW
-0.6%
Market Closed
Market Cap:
₩133.9B
Balance Sheet
Balance Sheet Decomposition
Nong Woo Bio Co Ltd
Nong Woo Bio Co Ltd
Balance Sheet Decomposition is not available for
Nong Woo Bio Co Ltd
Nong Woo Bio Co Ltd
Balance Sheet
Nong Woo Bio Co Ltd
Nong Woo Bio Co Ltd
Currency: KRW
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
12 877
|
14 060
|
12 506
|
21 024
|
17 253
|
20 996
|
15 457
|
24 130
|
34 445
|
39 751
|
|
| Cash Equivalents |
12 877
|
14 060
|
12 506
|
21 024
|
17 253
|
20 996
|
15 457
|
24 130
|
34 445
|
39 751
|
|
| Short-Term Investments |
279
|
238
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
|
| Total Receivables |
31 862
|
37 075
|
42 922
|
41 160
|
46 774
|
47 456
|
48 326
|
52 134
|
50 330
|
52 592
|
|
| Accounts Receivables |
30 063
|
35 025
|
41 316
|
39 332
|
44 535
|
45 920
|
47 759
|
51 427
|
49 676
|
51 110
|
|
| Other Receivables |
1 799
|
2 050
|
1 606
|
1 828
|
2 239
|
1 536
|
568
|
708
|
654
|
1 482
|
|
| Inventory |
62 681
|
65 919
|
73 087
|
82 842
|
92 902
|
98 908
|
110 950
|
117 859
|
109 779
|
116 196
|
|
| Other Current Assets |
2 547
|
2 501
|
1 756
|
4 691
|
2 772
|
2 893
|
4 665
|
6 943
|
7 165
|
5 830
|
|
| Total Current Assets |
110 246
|
119 794
|
130 271
|
149 717
|
159 701
|
170 253
|
179 398
|
201 066
|
201 720
|
214 387
|
|
| PP&E Net |
65 227
|
61 602
|
65 164
|
67 971
|
82 258
|
79 644
|
80 116
|
75 202
|
68 475
|
75 467
|
|
| PP&E Gross |
65 227
|
61 602
|
65 164
|
67 971
|
82 258
|
79 644
|
80 116
|
75 202
|
68 475
|
75 467
|
|
| Accumulated Depreciation |
32 126
|
34 760
|
40 319
|
42 851
|
48 043
|
49 440
|
54 280
|
53 522
|
46 114
|
51 985
|
|
| Intangible Assets |
3 285
|
3 214
|
7 657
|
5 077
|
3 640
|
4 897
|
4 679
|
4 304
|
2 805
|
2 597
|
|
| Goodwill |
0
|
0
|
0
|
2 972
|
2 972
|
2 972
|
1 827
|
751
|
480
|
480
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
754
|
91
|
0
|
|
| Long-Term Investments |
34 318
|
33 729
|
33 110
|
33 195
|
32 677
|
32 226
|
31 950
|
30 943
|
33 092
|
31 722
|
|
| Other Long-Term Assets |
3 871
|
2 900
|
3 705
|
5 321
|
8 616
|
11 699
|
13 079
|
14 372
|
17 146
|
18 657
|
|
| Other Assets |
0
|
0
|
0
|
2 972
|
2 972
|
2 972
|
1 827
|
751
|
480
|
480
|
|
| Total Assets |
216 947
N/A
|
221 239
+2%
|
239 907
+8%
|
264 253
+10%
|
289 864
+10%
|
301 692
+4%
|
311 049
+3%
|
327 393
+5%
|
323 809
-1%
|
343 309
+6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
12 348
|
10 926
|
11 220
|
11 684
|
13 609
|
16 410
|
15 993
|
18 535
|
16 460
|
19 838
|
|
| Accrued Liabilities |
4 767
|
8 313
|
8 200
|
9 488
|
10 957
|
11 816
|
12 298
|
11 430
|
11 908
|
12 302
|
|
| Short-Term Debt |
10 253
|
7 203
|
28 866
|
1 645
|
16 343
|
20 306
|
20 403
|
28 062
|
20 562
|
8 044
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
419
|
419
|
1 640
|
1 120
|
1 272
|
1 123
|
763
|
1 024
|
|
| Other Current Liabilities |
11 874
|
25 095
|
6 289
|
10 053
|
9 716
|
9 732
|
11 502
|
13 761
|
12 102
|
14 534
|
|
| Total Current Liabilities |
39 242
|
51 538
|
54 994
|
33 289
|
52 265
|
59 384
|
61 469
|
72 910
|
61 795
|
55 742
|
|
| Long-Term Debt |
0
|
0
|
8 591
|
571
|
4 138
|
4 654
|
4 550
|
2 958
|
2 693
|
14 538
|
|
| Deferred Income Tax |
322
|
49
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
90
|
72
|
874
|
910
|
924
|
80
|
82
|
692
|
625
|
755
|
|
| Other Liabilities |
1 139
|
1 771
|
1 654
|
1 738
|
1 707
|
1 452
|
1 313
|
1 391
|
1 330
|
1 464
|
|
| Total Liabilities |
40 793
N/A
|
53 430
+31%
|
66 112
+24%
|
36 509
-45%
|
59 034
+62%
|
65 570
+11%
|
67 414
+3%
|
77 950
+16%
|
66 442
-15%
|
72 499
+9%
|
|
| Equity | |||||||||||
| Common Stock |
7 150
|
7 150
|
7 150
|
8 015
|
8 015
|
8 015
|
8 015
|
8 015
|
8 015
|
8 015
|
|
| Retained Earnings |
132 197
|
124 649
|
133 956
|
160 120
|
161 958
|
168 151
|
171 876
|
178 650
|
185 777
|
193 410
|
|
| Additional Paid In Capital |
25 823
|
25 823
|
25 823
|
53 312
|
53 312
|
53 312
|
53 312
|
53 312
|
53 312
|
53 312
|
|
| Unrealized Security Profit/Loss |
57
|
81
|
2
|
14
|
22
|
233
|
670
|
848
|
2 157
|
1 746
|
|
| Other Equity |
10 926
|
10 106
|
6 864
|
6 284
|
7 524
|
6 410
|
9 762
|
8 617
|
8 106
|
14 328
|
|
| Total Equity |
176 153
N/A
|
167 809
-5%
|
173 795
+4%
|
227 744
+31%
|
230 831
+1%
|
236 121
+2%
|
243 634
+3%
|
249 442
+2%
|
257 366
+3%
|
270 811
+5%
|
|
| Total Liabilities & Equity |
216 947
N/A
|
221 239
+2%
|
239 907
+8%
|
264 253
+10%
|
289 864
+10%
|
301 692
+4%
|
311 049
+3%
|
327 393
+5%
|
323 809
-1%
|
343 309
+6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
16
|
16
|
16
|
16
|
16
|
16
|
16
|
|
Switch to:
Switch to:
See Also
Discover More
